The American Society of Anesthesiologists recommends temporarily halting the use of GLP-1 medications before planned procedures
Your kitchen counter overnight, roughly 8 to 10 hours at maybe 72 degrees, barely registers on that timeline
As a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management, semaglutide (marketed as Wegovy for obesity) represents a long-term treatment approach rather than a short-term solution
Tirzepatide users may experience slightly higher rates of nausea due to its dual-action mechanism, though this varies widely among individuals
Other common issues include vomiting, diarrhea, abdominal pain, and constipation
Improved Blood Sugar Management: Semaglutide helps regulate blood sugar, which is especially beneficial for individuals with prediabetes or insulin resistance